Meeting
2018 Gastrointestinal Cancers Symposium
Comprehensive genomic profiling (CGP) in KRAS wild-type (WT) pancreatic ductal adenocarcinoma (PDAC).
Authors
Ben George
Froedtert & the Medical College of Wisconsin, Milwaukee, WI
Ben George , Joel R. Greenbowe , Andrew Eugene Hendifar , Talia Golan , Milind M. Javle , Anirban Maitra , Nathan Bahary , Alexa Betzig Schrock , Philip J. Stephens , Vincent A. Miller , Jeffrey S. Ross , Evgeny Yakirevich , Paul S. Ritch , James P. Thomas , Siraj Mahamed Ali , Aatur D. Singhi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Translational Research
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 271)
DOI
10.1200/JCO.2018.36.4_suppl.271
Abstract #
271
Poster Bd #
D4
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Genomic profiling of KRAS wide-type pancreatic ductal adenocarcinomas identifies targetable genetic alterations.
First Author: Deng Wei
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Molecular genetic sequencing of neuroendocrine tumors of the gastrointestinal tract.
First Author: Alexandra Androsova
Poster
2020 Gastrointestinal Cancers Symposium
Phase II trial of the PARP inhibitor, niraparib, in BAP1 and other DNA damage response (DDR) pathway deficient neoplasms including cholangiocarcinoma.
First Author: Thomas J. George
Poster
2023 ASCO Annual Meeting
Effect of homologous recombination deficient (HRD) breast cancers on a distinct immune marker phenotype by comprehensive genomic and immune profiling (CGIP).
First Author: Heidi Chwan Ko